全文获取类型
收费全文 | 218篇 |
免费 | 6篇 |
国内免费 | 1篇 |
专业分类
儿科学 | 4篇 |
妇产科学 | 1篇 |
基础医学 | 32篇 |
口腔科学 | 4篇 |
临床医学 | 14篇 |
内科学 | 70篇 |
皮肤病学 | 2篇 |
神经病学 | 10篇 |
特种医学 | 2篇 |
外科学 | 30篇 |
预防医学 | 14篇 |
眼科学 | 1篇 |
药学 | 11篇 |
肿瘤学 | 30篇 |
出版年
2021年 | 5篇 |
2020年 | 11篇 |
2019年 | 8篇 |
2018年 | 8篇 |
2017年 | 3篇 |
2016年 | 6篇 |
2015年 | 7篇 |
2014年 | 5篇 |
2013年 | 8篇 |
2012年 | 16篇 |
2011年 | 15篇 |
2010年 | 8篇 |
2009年 | 8篇 |
2008年 | 14篇 |
2007年 | 9篇 |
2006年 | 14篇 |
2005年 | 21篇 |
2004年 | 18篇 |
2003年 | 8篇 |
2002年 | 12篇 |
2001年 | 3篇 |
2000年 | 3篇 |
1999年 | 2篇 |
1998年 | 1篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1995年 | 1篇 |
1994年 | 2篇 |
1987年 | 2篇 |
1984年 | 2篇 |
1981年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有225条查询结果,搜索用时 15 毫秒
101.
102.
Remo A Zanella C Molinari E Talamini A Tollini F Piacentini P Battaglia P Baritono E Bonetti A Lanza F Fasolin A Manfrin E Vendraminelli R 《International journal of surgical pathology》2012,20(2):185-190
Rhabdoid colon tumors (RCTs) are rare lesions whose existence as an independent distinct entity remains controversial. To date, 6 RCTs have been reported. This study reports a novel case associated with polyposis coli in a 73-year-old woman. Histologically, the neoplasia was heterogeneous consisting of an adenocarcinoma associated with rhabdoid features. In rhabdoid component, an intense expression of MSH2 was noted but MLH1 was negative. A BRAF V600E mutation and no KRAS mutations were identified. The promoter regions of subset of genes highly specific to characterize the CIMP status (NEUROG1, IGF2, RUNX3, SOCS1, including MLH1) were hypermethylated, suggesting the presence of CIMP+ and MSI high tumor. In conclusion, all RCTs have similar clinical features. The presence of polyposis and adenocarcinoma component as well as the expression of mesenchymal marker suggests a sarcomatous dedifferentiation. It is argued that RCT could be a very aggressive entity of colon, which could benefit from new biological colonic treatments. 相似文献
103.
Forti P Pirazzoli GL Maltoni B Bianchi G Magalotti D Muscari A Mariani E Ravaglia G Zoli M 《European journal of clinical investigation》2012,42(9):1000-1009
Eur J Clin Invest 2012; 42 (9): 1000-1009 ABSTRACT: Background Prevalence of metabolic syndrome (MetS) increases with age, but its association with all-cause mortality in older persons remains uncertain. This study investigated the association of all-cause mortality with MetS and its individual components in older men and women. Methods A total of 917 men and 1043 women aged 65?years and older from two Italian population-based cohorts were included in the study. MetS was defined according to four different definitions: National Cholesterol Education Program (NCEP), NCEP revised according to the American Heart Association and National Heart Lung Blood Institute (NCEP-R), International Diabetes Organization (IDF) and Joint Interim Statement (JIS). All of these definitions include abdominal obesity, hyperglycaemia, hypertriglyceridaemia, low high-density lipoprotein cholesterol and hypertension. Hazard Ratios (HR) and their corresponding 95% confidence interval (95%CI) estimated from multivariable-adjusted Cox regression models were used to investigate the associations of all-cause mortality with baseline MetS status and individual MetS components. Results After 6·5?±?1·8?years of follow-up, there were 179 deaths among women and 193 among men. Mortality risk was increased in women with MetS by any definition, regardless of individual components, but limited to age 70-79?years (NCEP, HR?=?2·02, 95%CI, 1·16-3·53; NCEP-R, HR?=?2·51, 95%CI, 1·45-4·34; IDF, HR?=?2·16, 95%CI, 1·26-3·72; JIS, HR?=?2·16, 95%CI, 1·26-3·72). Mortality risk of men was associated with hypertriglyceridaemia below age 70?years (HR?=?2·50, 95%CI, 1·19-5·25), but unrelated to MetS status. Conclusions Metabolic Syndrome is associated with all-cause mortality in older women but not in men. The association, however, is limited to a narrow age range. 相似文献
104.
Brunello E Brunelli M Manfrin E Nottegar A Bersani S Vergine M Molino A Fiorio E Chilosi M Gobbo S Martignoni G Bonetti F 《Histopathology》2012,60(3):482-488
Brunello E, Brunelli M, Manfrin E, Nottegar A, Bersani S, Vergine M, Molino A, Fiorio E, Chilosi M, Gobbo S, Martignoni G & Bonetti F (2012) Histopathology 60, 482–488 Classical lobular breast carcinoma consistently lacks topoisomerase‐IIα gene amplification: implications for the tailored use of anthracycline‐based chemotherapies [Correction added after online publication, 17 January 2012: Title amended to match main article title.] Aims: There is consistent lack of data focusing the topoisomerase‐IIα gene status in lobular breast carcinoma, a subtype that usually shows poor responsiveness to chemotherapies including those using anthracycline drugs. Methods and results: Forty‐six infiltrative lobular carcinomas, 13 with matched metastases, were used. Topoisomerase‐IIα gene amplification was evaluated by chromogenic in situ hybridization (CISH) and fluorescence in situ hybridization (FISH). We also assessed Her2/neu status by CISH, FISH and silver in situ hybridization (SISH). HER2 immunoexpression was assessed by the HercepTest. Forty‐four of 46 (95%) cases revealed no topoisomerase‐IIα amplification, whereas two of 46 (5%) cases were amplified by all three techniques. Eleven of the 13 metastatic sites showed no amplification either in the primary or in the metastases (85%); the remaining two were amplified (15%). Her2/neu was not amplified in 44 of 46 (95%) cases nor was it amplified in 11 of 13 (95%) metastatic tissues. The two cases showing Her2/neu and topoisomerase‐IIα amplification scored 3+; the remaining non‐amplified cases scored 0 or 1+ in 40 and 2+ in four cases. Conclusions: In the era of personalized and tailored therapies, we suggest that patients affected by the classical lobular subtype of breast carcinoma constantly lack the ad hoc predictive rationale for receiving common chemotherapy that includes anthracyclines. 相似文献
105.
106.
Pischke CR Weidner G Elliott-Eller M Scherwitz L Merritt-Worden TA Marlin R Lipsenthal L Finkel R Saunders D McCormac P Scheer JM Collins RE Guarneri EM Ornish D 《The American journal of cardiology》2006,97(9):1267-1273
It is unclear whether patients with coronary artery disease (CAD) and diabetes mellitus (DM) can make comprehensive lifestyle changes that produce similar changes in coronary risk factors and quality of life compared with patients with CAD and without DM. We examined medical characteristics, lifestyle, and quality of life by diabetic status and gender in the Multicenter Lifestyle Demonstration Project (MLDP), a study of 440 nonsmoking patients with CAD (347 men, 55 with DM; 15.9%; 93 women, 36 with DM; 38.7%). Patients met in groups to improve lifestyle (plant-based, low-fat diet; exercise; stress management) for 1 year. Follow-ups were conducted at 3 and 12 months. At baseline, body mass and systolic blood pressure were significantly higher among patients with DM. Men with DM had a worse medical history (e.g., hypertension, hyperlipidemia, and family history of CAD) than did those without DM. Patients with DM, especially women, reported poorer quality of life than did patients without DM. The 2 groups of patients were able to adhere to the recommended lifestyle, as demonstrated by significant improvements in weight (mean -5 kg), body fat, low-density lipoprotein cholesterol, exercise capacity, and quality of life. No significant changes in triglycerides and high-density lipoprotein cholesterol were noted. By the end of 12 months, improvements in glucose-lowering medications (i.e., discontinuation or a change from insulin to oral hypoglycemic agents) were noted for 19.8% (n = 18) of patients with DM. In conclusion, patients with CAD and DM are able to follow a comprehensive lifestyle change program and show similar improvements in coronary risk factors and quality of life as those without DM. 相似文献
107.
Simona Neri Erminia Mariani Alessandra Meneghetti Luca Cattini Andrea Facchini 《Clinical and Vaccine Immunology : CVI》2001,8(6):1131-1135
Cytotoxicity assays provide an in vitro evaluation of the lytic activity of NK and T cells against tumors or transformed cells. However, none of these methods allow the recovery of cells or supernatants after the assay. We standardized a microcytotoxicity test using calcein-acetoxymethyl (calcein-AM) dye that requires very small quantities of cells while maintaining the same sensitivity as the traditional 51Cr assay. The assay is applicable to resting as well as activated human effector cells and uses different targets such as human cell lines that are adherent or growing in suspension and resistant or sensitive. The most important feature of the method is the possibility of recovering cells and supernatants for additional analyses such as phenotyping and evaluation of soluble factors. 相似文献
108.
Costa Marta Squassina Alessio Piras Ignazio Stefano Pisanu Claudia Congiu Donatella Niola Paola Angius Andrea Chillotti Caterina Ardau Raffaella Severino Giovanni Stochino Erminia Deidda Arianna Persico Antonio M. Alda Martin Del Zompo Maria 《Journal of molecular neuroscience : MN》2015,56(3):688-695
Journal of Molecular Neuroscience - Bipolar disorder (BD) and cluster headache (CH) are distinct conditions with important similarities such as a temporal pattern of disturbances, dysregulation of... 相似文献
109.
Erminia Colucci Claire M Kelly Harry Minas Anthony F Jorm Dinah Nadera 《International journal of mental health systems》2010,4(1):32
Background
This study aimed to develop guidelines for how a member of the Filipino public should provide mental health first aid to a person who is suicidal. 相似文献110.